From: A potential anatomic subtype of short bowel syndrome: a matched case-control study
Characteristic | IP group (n = 24) | JP group (n = 48) | p value |
---|---|---|---|
Time of PN (Mean ± SD, d) | 10.8 ± 2.8 | 10.7 ± 2.4 | 0.87 |
Time of PN+EN | 7.5 ± 3.1 | 10.3 ± 3.7 | 0.002 |
Time of EN | 4.4 ± 1.7 | 4.8 ± 2.0 | 0.42 |
Intestinal rehabilitation therapy | 8(33 %) | 20(42 %) | 0.49 |
Complications in hospital a, b | |||
Diarrhea | 21(88 %) | 41(85 %) | 0.71 |
Catheter-related infections | 2(8.3 %) | 3(6.3 %) | 0.34 |
Steatosis | 11(46 %) | 19(40 %) | 0.61 |
Cholestasis | 5(21 %) | 12(25 %) | 0.22 |
Gallbladder sludge/stones | 1(4 %) | 5(10 %) | 0.26 |
Metabolic bone disease c | 2(8 %) | 3(6 %) | 0.34 |
Renal insufficiency | 1(4 %) | 1(2 %) | 0.45 |
Complications during follow-up a | |||
Death | 1(4 %) | 2(4 %) | 0.45 |
Catheter-related infections | 7(29 %) | 16(33 %) | 0.20 |
Steatosis | 13(54 %) | 23(48 %) | 0.62 |
Cholestasis | 8(33 %) | 17(35 %) | 0.86 |
Renal insufficiency | 2(8 %) | 5(10 %) | 0.32 |
Nephrolithiasis d | 1(4 %) | 6(13 %) | 0.20 |
Gallbladder sludge/stones d | 1(4 %) | 5(10 %) | 0.26 |
Metabolic bone disease d | |||
All cases | 0(0 %) | 2(4 %) | 0.44 |
Tested cases | 0/5(0 %) | 2/8(25 %) | 0.43 |